Cargando…
Is aripiprazole a key to unlock anorexia nervosa?: A case series
Aripiprazole contributes an increase in body mass index and attenuation in anorexia nervosa (AN) symptoms, leading clinical improvements with lower side‐effect profile; but it is not enough to cure comorbid depressive symptoms in AN.
Autores principales: | Tahıllıoğlu, Akın, Özcan, Tuğçe, Yüksel, Gamze, Majroh, Noorjahan, Köse, Sezen, Özbaran, Burcu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752603/ https://www.ncbi.nlm.nih.gov/pubmed/33363831 http://dx.doi.org/10.1002/ccr3.3271 |
Ejemplares similares
-
Changes in the psychosocial and clinical profiles of anorexia nervosa patients during the pandemic
por: Özbaran, N. Burcu, et al.
Publicado: (2023) -
Editorial: New Perspectives to Unlock the Current Impasse in Treating Anorexia Nervosa
por: Gutierrez, Emilio, et al.
Publicado: (2020) -
Anorexia nervosa in the times of COVID-19 pandemic is it different than before?
por: Yılancıoğlu, H. Y., et al.
Publicado: (2023) -
ANOREXIA NERVOSA
por: Chaudhury, S., et al.
Publicado: (2001) -
Severe-Enduring Anorexia Nervosa (SE-AN): a case series
por: Marcolini, Federica, et al.
Publicado: (2023)